Prof Antoni Martinez-Rubio speaks with Cardio Debate and Radcliffe Cardiology about assessing risk of bleeding in patients with atrial fibrillation who require new oral anticoagulants (NOACs) during the ESC Congress 2015 in London, UK.
Assessing risk of bleeding in patients who require NOACs
Related articles
09/30/2018 - COMPASS helps lead the way to earlier cancer diagnosis in CVD patients - Sian Claire Owen, medical journalist for Cardio Debate, UK
02/05/2018 - Uninterrupted apixaban therapy vs. warfarin during AF ablation: A question of safety and efficacy - Dr Amelia Carro Hevia, Spain
01/27/2016 - More attention needed for the uterus in Cardiology - Prof Angela Maas, The Netherlands
01/04/2016 - Dual antiplatelet therapy in unstable angina – Prof Gislasen - Professor Gunnar Gislasen, Gentofte University Hospital, Denmark
12/28/2015 - Sudden Cardiac Death Syndrome in South Asians living in the UK - Dr Rajay Narain, Clinical and Research Cardiologist, St George’s University of London, UK
12/21/2015 - Research into resistant hypertension: Looking to the future - Professor Sverre Kjeldsend, Oslo University Hospital Ullevaal, Norway
12/07/2015 - CANTOS and CIRT TRIALS: Does lowering inflammation lower vascular risk? - Prof Paul M. Ridker, Eugene Braunwald Professor of Medicine at Harvard University, USA
12/03/2015 - Healing broken hearts: Takotsubo prognosis ‘quite good’ - Professor Juan Carlos Kaski, Director of the Cardiovascular and Cell Sciences Research Institute at St George’s University of London, UK
11/24/2015 - MINOCA diagnosis and finding underlying cause - Professor John Beltrame, Professor of Medicine, The Queen Elizabeth Hospital, University of Adelaide, Australia
11/24/2015 - Renal denervation in 2015 - Dr Justin E. Davies, Consultant Cardiologist, Imperial College London, London, UK
Leave a Reply
You must be logged in to post a comment.